Read the full article: Will This Fish Transform Medicine? (POPSCI)
For many of us, having our genomes in hand today isn’t likely to make any profound difference in our lives, at least not when it comes to our health. But for children and their families affected by rare and mysterious genetic diseases, early indications are that it’s a completely different story, thanks to the efforts of two teams of geneticists at Duke Medicine.
Read the full article: An End to Odysseys (GenomeLIFE)
Combining genome sequencing and functional assays, the Duke Task Force for Neonatal Genomics aims to assist in the early diagnosis of newborns and young children with challenging genetic diseases.
Read the full article: Duke Team Combines Sequencing, Functional Assays for Diagnosing Children with Congenital Disorders (GenomeWeb)
Researchers at Duke University Medical Center have received two competitive grants from the National Institute of Diabetes and Digestive and Kidney Diseases, part of the National Institutes of Health. Nicholas Katsanis, PhD, the Jean and George W. Brumley professor of cell biology and pediatrics, has also been awarded funding through the NIDDK’s O’Brien Center program.
Read the full article: Duke Wins Grants to Support Research in Kidney, Urologic Health (Nephrology News)
The Milwaukee-Wisconsin Journal Sentinel published an article this week discussing how Duke researchers are analyzing genetic blueprints of unborn and newborn babies to investigate rare conditions.
Nicholas Katsanis, PhD, a professor of cell biology and pediatrics who leads a task force on neonatal genomics at Duke University Hospital, provided commentary on Duke’s innovative research.
Read the full article: Nic Volker Case May Be the Leading Edge of a Wave Moving Across Genetic Medicine (jsonline.com)